Literature DB >> 17100609

Biomolecular interaction analysis in drug discovery using surface plasmon resonance technology.

Walter Huber1, Francis Mueller.   

Abstract

The review gives first an introduction into the basics of surface plasmon resonance technology. The physical principle is shortly discussed followed by a discussion of the experimental details to be considered when using this technology for biomolecular interaction analysis. Based on recent publications it is demonstrated that the technology has widespread applications in many fields of the drug discovery process. Protein/protein interactions can be monitored in real time when working with biopharmaceuticals as well as protein/small analyte interactions during hit finding, secondary screening, lead optimization and lead selection. Equilibrium binding constants, kinetic rate constants and thermodynamic parameters are obtained from such study that helps to understand the mechanism of the binding reactions. This information can be directly used to improve binding properties of a drug candidate.

Mesh:

Substances:

Year:  2006        PMID: 17100609     DOI: 10.2174/138161206778743600

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  18 in total

1.  Native serotonin membrane receptors recognize 5-hydroxytryptophan-functionalized substrates: enabling small-molecule recognition.

Authors:  Amit Vaish; Mitchell J Shuster; Sarawut Cheunkar; Yogesh S Singh; Paul S Weiss; Anne M Andrews
Journal:  ACS Chem Neurosci       Date:  2010-04-09       Impact factor: 4.418

Review 2.  Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding.

Authors:  Vijay M Krishnamurthy; George K Kaufman; Adam R Urbach; Irina Gitlin; Katherine L Gudiksen; Douglas B Weibel; George M Whitesides
Journal:  Chem Rev       Date:  2008-03       Impact factor: 60.622

3.  A fluorescence-based high throughput assay for the determination of small molecule-human serum albumin protein binding.

Authors:  Megan M McCallum; Alan J Pawlak; William R Shadrick; Anton Simeonov; Ajit Jadhav; Adam Yasgar; David J Maloney; Leggy A Arnold
Journal:  Anal Bioanal Chem       Date:  2014-01-05       Impact factor: 4.142

Review 4.  Protein-protein interactions: switch from classical methods to proteomics and bioinformatics-based approaches.

Authors:  Armand G Ngounou Wetie; Izabela Sokolowska; Alisa G Woods; Urmi Roy; Katrin Deinhardt; Costel C Darie
Journal:  Cell Mol Life Sci       Date:  2013-04-12       Impact factor: 9.261

5.  Quantitative monitoring of two simultaneously binding species using Label-Enhanced surface plasmon resonance.

Authors:  Lars Eng; Brandon L Garcia; Brian V Geisbrecht; Anders Hanning
Journal:  Biochem Biophys Res Commun       Date:  2018-02-07       Impact factor: 3.575

Review 6.  Biophysics in drug discovery: impact, challenges and opportunities.

Authors:  Jean-Paul Renaud; Chun-Wa Chung; U Helena Danielson; Ursula Egner; Michael Hennig; Roderick E Hubbard; Herbert Nar
Journal:  Nat Rev Drug Discov       Date:  2016-08-12       Impact factor: 84.694

7.  Cellular membrane phospholipids act as a depository for quaternary amine containing drugs thus competing with the acetylcholine/nicotinic receptor.

Authors:  Damon Barbacci; Shelley N Jackson; Ludovic Muller; Thomas Egan; Ernest K Lewis; J Albert Schultz; Amina S Woods
Journal:  J Proteome Res       Date:  2012-04-30       Impact factor: 4.466

Review 8.  Fragment screening and HIV therapeutics.

Authors:  Joseph D Bauman; Disha Patel; Eddy Arnold
Journal:  Top Curr Chem       Date:  2012

9.  Binding of EGF1 domain peptide in coagulation factor VII with tissue factor and its implications for the triggering of coagulation.

Authors:  Heng Mei; Yu Hu; Huafang Wang; Wei Shi; Jun Deng; Tao Guo
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-02-14

Review 10.  Surface plasmon resonance as a high throughput method to evaluate specific and non-specific binding of nanotherapeutics.

Authors:  Craig S Schneider; Adip G Bhargav; Jimena G Perez; Aniket S Wadajkar; Jeffrey A Winkles; Graeme F Woodworth; Anthony J Kim
Journal:  J Control Release       Date:  2015-09-28       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.